For patients with eGFR between 30-45 mL/min/1.73 m, a careful reassessment of benefit-risk is recommended with consideration of dose reduction
USA 105 , 1878218787 (2008)
Latest Ozempic Lawsuit Updates As of July 2026, there are 3,848 personal injury lawsuits for gastroparesis, ileus and intestinal obstruction in MDL 3094 in the Eastern District of Pennsylvania
Propionyl-L-carnitine shows particular promise for peripheral vascular disease and heart failure, with some trials demonstrating improved exercise tolerance.[8][9] LCAR supplementation improves glucolipid metabolism, reducing fasting glucose, insulin resistance, triglycerides, and liver enzymes.[10] Both compounds exhibit excellent safety profiles with minimal side-effects, though recent data raises concerns about substantial TMAO production (reaching 50 M plasma levels) from both supplements, which may have adverse cardiovascular implications.[1][8][3] References Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders